KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 85 filers reported holding KALA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 7.30 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -97.2% | 15,600 | -88.1% | 0.00% | – |
| Q1 2022 | $180,000 | -14.7% | 130,795 | -25.0% | 0.00% | – |
| Q4 2021 | $211,000 | -40.1% | 174,357 | +29.9% | 0.00% | – |
| Q3 2021 | $352,000 | +16.9% | 134,257 | +136.5% | 0.00% | – |
| Q2 2021 | $301,000 | +3.1% | 56,757 | +31.1% | 0.00% | – |
| Q1 2021 | $292,000 | +22.7% | 43,288 | +23.1% | 0.00% | – |
| Q4 2020 | $238,000 | +108.8% | 35,159 | +131.9% | 0.00% | – |
| Q3 2020 | $114,000 | -96.0% | 15,159 | -94.4% | 0.00% | – |
| Q2 2020 | $2,825,000 | +1082.0% | 268,759 | +328.5% | 0.00% | – |
| Q3 2019 | $239,000 | -85.0% | 62,724 | -74.8% | 0.00% | – |
| Q2 2019 | $1,590,000 | -28.3% | 249,223 | -7.0% | 0.00% | – |
| Q1 2019 | $2,217,000 | +52.3% | 268,071 | -10.0% | 0.00% | – |
| Q4 2018 | $1,456,000 | -64.1% | 297,731 | -27.6% | 0.00% | -100.0% |
| Q3 2018 | $4,057,000 | – | 411,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |